{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:31:07Z","timestamp":1792636267334,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1172-6","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T14:08:22Z","timestamp":1551881302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review"],"prefix":"10.1186","volume":"10","author":[{"given":"Colin M.","family":"Suen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Montroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Levac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Wesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauralyn","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-382X","authenticated-orcid":false,"given":"Manoj M.","family":"Lalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"issue":"25 Suppl","key":"1172_CR1","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"1172_CR2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250\u201394.","journal-title":"Circulation."},{"issue":"1","key":"1172_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2009.12.006","volume":"126","author":"P Jurasz","year":"2010","unstructured":"Jurasz P, Courtman D, Babaie S, Stewart DJ. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials. Pharmacol Ther. 2010;126(1):1\u20138.","journal-title":"Pharmacol Ther"},{"issue":"12 Suppl S","key":"1172_CR4","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","volume":"43","author":"M Humbert","year":"2004","unstructured":"Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):13S\u201324S.","journal-title":"J Am Coll Cardiol"},{"key":"1172_CR5","doi-asserted-by":"crossref","unstructured":"Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8(8):443-55.","DOI":"10.1038\/nrcardio.2011.87"},{"issue":"4","key":"1172_CR6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/cphy.c120034","volume":"3","author":"CM Suen","year":"2013","unstructured":"Suen CM, Mei SH, Kugathasan L, Stewart DJ. Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases. Comprehensive Physiology. 2013;3(4):1749\u201379.","journal-title":"Comprehensive Physiology"},{"issue":"7","key":"1172_CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCRESAHA.114.305951","volume":"117","author":"J Granton","year":"2015","unstructured":"Granton J, Langleben D, Kutryk MB, Camack N, Galipeau J, Courtman DW, et al. Endothelial NO-synthase gene-enhanced progenitor cell therapy for pulmonary arterial hypertension: the PHACeT trial. Circ Res. 2015;117(7):645\u201354.","journal-title":"Circ Res"},{"key":"1172_CR8","doi-asserted-by":"crossref","unstructured":"Foster WS, Suen CM, Cell SDJ. Tissue-based regenerative therapies for pulmonary arterial hypertension. Can J Cardiol. 2014.","DOI":"10.1016\/j.cjca.2014.08.022"},{"issue":"4","key":"1172_CR9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7434","volume":"5","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5(4):434\u20138.","journal-title":"Nat Med"},{"issue":"14","key":"1172_CR10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2006.12.037","volume":"49","author":"X-X Wang","year":"2007","unstructured":"Wang X-X, Zhang F-R, Shang Y-P, Zhu J-H, Xie X-D, Tao Q-M, et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol. 2007;49(14):1566\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1172_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1399-3046.2007.00863.x","volume":"12","author":"JH Zhu","year":"2008","unstructured":"Zhu JH, Wang XX, Zhang FR, Shang YP, Tao QM, Zhu JH, et al. Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. Pediatr Transplant. 2008;12(6):650\u20135.","journal-title":"Pediatr Transplant"},{"key":"1172_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-016-0265-x","volume":"5","author":"CM Suen","year":"2016","unstructured":"Suen CM, Zhai A, Lalu MM, Welsh C, Levac BM, Fergusson D, et al. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol. Syst Rev. 2016;5:89.","journal-title":"Syst Rev"},{"key":"1172_CR13","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","DOI":"10.1136\/bmj.b2535"},{"key":"1172_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-662-45805-1_5","volume":"218","author":"JJ Ryan","year":"2013","unstructured":"Ryan JJ, Marsboom G, Archer SL. Rodent models of group 1 pulmonary hypertension. Handb Exp Pharmacol. 2013;218:105\u201349.","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"1172_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.18438\/B8SG8R","volume":"5","author":"J McGowan","year":"2010","unstructured":"McGowan J, Sampson M, Lefebvre C. An evidence based checklist for the peer review of electronic search strategies (PRESS EBC). Evid Based Libr Inf Pract. 2010;5(1):149\u201354.","journal-title":"Evid Based Libr Inf Pract"},{"issue":"1","key":"1172_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"1172_CR17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"6","key":"1172_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2188\/jea.15.235","volume":"15","author":"Y Hayashino","year":"2005","unstructured":"Hayashino Y, Noguchi Y, Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol. 2005;15(6):235\u201343.","journal-title":"J Epidemiol"},{"issue":"5\u20136","key":"1172_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/1076327041348563","volume":"10","author":"M Takahashi","year":"2004","unstructured":"Takahashi M, Nakamura T, Toba T, Kajiwara N, Kato H, Shimizu Y. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng. 2004;10(5\u20136):771\u20139.","journal-title":"Tissue Eng"},{"issue":"4","key":"1172_CR20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-11-1175","volume":"76","author":"Y Luan","year":"2012","unstructured":"Luan Y, Zhang Z-H, Wei D-E, Lu Y, Wang Y-B. Effects of autologous bone marrow mononuclear cells implantation in canine model of pulmonary hypertension. Circ J. 2012;76(4):977\u201385.","journal-title":"Circ J"},{"issue":"2","key":"1172_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","volume":"15","author":"L Taraseviciene-Stewart","year":"2001","unstructured":"Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 2001;15(2):427\u201338.","journal-title":"FASEB J"},{"issue":"5","key":"1172_CR22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1165\/rcmb.2009-0152OC","volume":"43","author":"ML Ormiston","year":"2010","unstructured":"Ormiston ML, Deng Y, Stewart DJ, Courtman DW. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am J Respir Cell Mol Biol. 2010;43(5):546\u201354.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1172_CR23","doi-asserted-by":"crossref","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.","DOI":"10.1136\/bmj.j5492"},{"issue":"24","key":"1172_CR24","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","volume":"58","author":"MC Veerdonk van de","year":"2011","unstructured":"van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol. 2011;58(24):2511\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1172_CR25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","volume":"115","author":"JJ Ryan","year":"2014","unstructured":"Ryan JJ, Archer SL. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res. 2014;115(1):176\u201388.","journal-title":"Circ Res"},{"issue":"6","key":"1172_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098856","volume":"9","author":"JA Hirst","year":"2014","unstructured":"Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, et al. The need for randomization in animal trials: an overview of systematic reviews. PLoS One. 2014;9(6):e98856.","journal-title":"PLoS One"},{"issue":"7","key":"1172_CR27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.117.312579","volume":"122","author":"S Provencher","year":"2018","unstructured":"Provencher S, Archer SL, Ramirez FD, Hibbert B, Paulin R, Boucherat O, et al. Standards and methodological rigor in pulmonary arterial hypertension preclinical and translational research. Circ Res. 2018;122(7):1021\u201332.","journal-title":"Circ Res"},{"issue":"7","key":"1172_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001489","volume":"10","author":"VC Henderson","year":"2013","unstructured":"Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med. 2013;10(7):e1001489.","journal-title":"PLoS Med"},{"issue":"6","key":"1172_CR29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9343(03)00013-5","volume":"114","author":"DG Contopoulos-Ioannidis","year":"2003","unstructured":"Contopoulos-Ioannidis DG, Ntzani E, Ioannidis JP. Translation of highly promising basic science research into clinical applications. Am J Med. 2003;114(6):477\u201384.","journal-title":"Am J Med"},{"issue":"5","key":"1172_CR30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MAJ.0b013e31822dc5d3","volume":"343","author":"Y Luan","year":"2012","unstructured":"Luan Y, Zhang ZH, Wei DE, Zhao JJ, Kong F, Cheng GH, et al. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension. Am J Med Sci. 2012;343(5):402\u20136.","journal-title":"Am J Med Sci"},{"key":"1172_CR31","doi-asserted-by":"crossref","unstructured":"Granton J, Langleben D, Kutryk M, Camac N, Galipeau J, Courtman D, Stewart D. Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension. Circ Res. 2015;117:645\u201354.","DOI":"10.1161\/CIRCRESAHA.114.305951"},{"issue":"7","key":"1172_CR32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.0000079161.56080.22","volume":"108","author":"N Nagaya","year":"2003","unstructured":"Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N, et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation. 2003;108(7):889\u201395.","journal-title":"Circulation."},{"issue":"4","key":"1172_CR33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000157672.70560.7b","volume":"96","author":"YD Zhao","year":"2005","unstructured":"Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, Stewart DJ. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res. 2005;96(4):442\u201350.","journal-title":"Circ Res"},{"issue":"1 Suppl","key":"1172_CR34","first-page":"I181","volume":"114","author":"S Kanki-Horimoto","year":"2006","unstructured":"Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation. 2006;114(1 Suppl):I181\u20135.","journal-title":"Circulation."},{"issue":"2","key":"1172_CR35","doi-asserted-by":"crossref","first-page":"H1120","DOI":"10.1152\/ajpheart.00173.2006","volume":"292","author":"SR Baber","year":"2007","unstructured":"Baber SR, Deng W, Master RG, Bunnell BA, Taylor BK, Murthy SN, et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007;292(2):H1120\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1172_CR36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/CCM.0B013E318165B7EA","volume":"36","author":"HK Yip","year":"2008","unstructured":"Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, et al. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Crit Care Med. 2008;36(3):873\u201380.","journal-title":"Crit Care Med"},{"issue":"3","key":"1172_CR37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.109.154328","volume":"330","author":"CK Sun","year":"2009","unstructured":"Sun CK, Lee FY, Sheu JJ, Yuen CM, Chua S, Chung SY, et al. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats. J Pharmacol Exp Ther. 2009;330(3):718\u201326.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1172_CR38","doi-asserted-by":"crossref","first-page":"H1606","DOI":"10.1152\/ajpheart.00590.2009","volume":"297","author":"S Umar","year":"2009","unstructured":"Umar S, de Visser YP, Steendijk P, Schutte CI, el Laghmani H, Wagenaar GT, et al. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2009;297(5):H1606\u201316.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1172_CR39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00395-009-0065-8","volume":"105","author":"K Takemiya","year":"2010","unstructured":"Takemiya K, Kai H, Yasukawa H, Tahara N, Kato S, Imaizumi T. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats. Basic Res Cardiol. 2010;105(3):409\u201317.","journal-title":"Basic Res Cardiol"},{"issue":"11","key":"1172_CR40","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.healun.2011.07.017","volume":"30","author":"A Angelini","year":"2011","unstructured":"Angelini A, Castellani C, Ravara B, Franzin C, Pozzobon M, Tavano R, et al. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. J Heart Lung Transplant. 2011;30(11):1281\u201393.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"1172_CR41","doi-asserted-by":"crossref","first-page":"L12","DOI":"10.1152\/ajplung.00215.2010","volume":"301","author":"R Mirsky","year":"2011","unstructured":"Mirsky R, Jahn S, Koskenvuo JW, Sievers RE, Yim SM, Ritner C, et al. Treatment of pulmonary arterial hypertension with circulating angiogenic cells. Am J Physiol Lung Cell Mol Physiol. 2011;301(1):L12\u20139.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"1172_CR42","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3727\/096368912X640529","volume":"21","author":"L Jiang","year":"2012","unstructured":"Jiang L, Song XH, Liu P, Zeng CL, Huang ZS, Zhu LJ, et al. Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension. Cell Transplant. 2012;21(7):1463\u201375.","journal-title":"Cell Transplant"},{"issue":"6","key":"1172_CR43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3346\/jkms.2012.27.6.605","volume":"27","author":"KC Kim","year":"2012","unstructured":"Kim KC, Lee HR, Kim SJ, Cho MS, Hong YM. Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension. J Korean Med Sci. 2012;27(6):605\u201313.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"1172_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2011.05.002","volume":"162","author":"CK Sun","year":"2012","unstructured":"Sun CK, Lin YC, Yuen CM, Chua S, Chang LT, Sheu JJ, et al. Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats. Int J Cardiol. 2012;162(1):45\u201358.","journal-title":"Int J Cardiol"},{"issue":"6","key":"1172_CR45","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s11596-012-1039-x","volume":"32","author":"J Xie","year":"2012","unstructured":"Xie J, Hu D, Niu L, Qu S, Wang S, Liu S. Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats. J Huazhong Univ Sci Technolog Med Sci. 2012;32(6):810\u20137.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"2","key":"1172_CR46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcyt.2012.09.002","volume":"15","author":"CH Yen","year":"2013","unstructured":"Yen CH, Tsai TH, Leu S, Chen YL, Chang LT, Chai HT, et al. Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension. Cytotherapy. 2013;15(2):209\u201323.","journal-title":"Cytotherapy."},{"issue":"9","key":"1172_CR47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/CIRCULATIONAHA.113.003139","volume":"128","author":"L Zhou","year":"2013","unstructured":"Zhou L, Chen Z, Vanderslice P, So SP, Ruan KH, Willerson JT, et al. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits. Circulation. 2013;128(9):982\u201394.","journal-title":"Circulation."},{"issue":"9","key":"1172_CR48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/aps.2014.61","volume":"35","author":"JY Chen","year":"2014","unstructured":"Chen JY, An R, Liu ZJ, Wang JJ, Chen SZ, Hong MM, et al. Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats. Acta Pharmacol Sin. 2014;35(9):1121\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"1172_CR49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.lfs.2014.05.008","volume":"118","author":"M Eguchi","year":"2014","unstructured":"Eguchi M, Ikeda S, Kusumoto S, Sato D, Koide Y, Kawano H, et al. Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats. Life Sci. 2014;118(2):306\u201312.","journal-title":"Life Sci"},{"issue":"4","key":"1172_CR50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00380-013-0395-1","volume":"29","author":"Y Guo","year":"2014","unstructured":"Guo Y, Su L, Li Y, Guo N, Xie L, Zhang D, et al. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats. Heart Vessel. 2014;29(4):520\u201331.","journal-title":"Heart Vessel"},{"issue":"4","key":"1172_CR51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10238-013-0256-3","volume":"14","author":"Y Luan","year":"2014","unstructured":"Luan Y, Zhang X, Qi TG, Cheng GH, Sun C, Kong F. Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension. Clin Exp Med. 2014;14(4):439\u201346.","journal-title":"Clin Exp Med"},{"issue":"8","key":"1172_CR52","doi-asserted-by":"crossref","first-page":"H1187","DOI":"10.1152\/ajpheart.00589.2013","volume":"307","author":"NK Somanna","year":"2014","unstructured":"Somanna NK, Worner PM, Murthy SN, Pankey EA, Schachtele DJ, St Hilaire RC, et al. Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol. 2014;307(8):H1187\u201395.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1172_CR53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yjmcc.2015.07.019","volume":"86","author":"M Ikutomi","year":"2015","unstructured":"Ikutomi M, Sahara M, Nakajima T, Minami Y, Morita T, Hirata Y, et al. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation. J Mol Cell Cardiol. 2015;86:121\u201335.","journal-title":"J Mol Cell Cardiol"},{"issue":"14","key":"1172_CR54","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1089\/scd.2014.0496","volume":"24","author":"H Kang","year":"2015","unstructured":"Kang H, Kim KH, Lim J, Kim YS, Heo J, Choi J, et al. The therapeutic effects of human mesenchymal stem cells primed with sphingosine-1 phosphate on pulmonary artery hypertension. Stem Cells Dev. 2015;24(14):1658\u201371.","journal-title":"Stem Cells Dev"},{"issue":"5","key":"1172_CR55","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3346\/jkms.2015.30.5.576","volume":"30","author":"H Lee","year":"2015","unstructured":"Lee H, Lee JC, Kwon JH, Kim KC, Cho MS, Yang YS, et al. The effect of umbilical cord blood derived mesenchymal stem cells in monocrotaline-induced pulmonary artery hypertension rats. J Korean Med Sci. 2015;30(5):576\u201385.","journal-title":"J Korean Med Sci"},{"issue":"suppl_F","key":"1172_CR56","doi-asserted-by":"crossref","first-page":"F4","DOI":"10.1093\/eurheartj\/suv049","volume":"17","author":"M Liang","year":"2015","unstructured":"Liang M, Li H, Zheng S, Ning J, Xu C, Wang H, et al. Comparison of early and delayed transplantation of adipose tissue-derived mesenchymal stem cells on pulmonary arterial function in monocrotaline-induced pulmonary arterial hypertensive rats. Eur Heart J Suppl. 2015;17(suppl_F):F4\u2013F12.","journal-title":"Eur Heart J Suppl"},{"issue":"5","key":"1172_CR57","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3892\/etm.2015.2722","volume":"10","author":"J Liu","year":"2015","unstructured":"Liu J, Han Z, Han Z, He Z. Mesenchymal stem cells suppress CaN\/NFAT expression in the pulmonary arteries of rats with pulmonary hypertension. Exp Ther Med. 2015;10(5):1657\u201364.","journal-title":"Exp Ther Med"},{"issue":"3","key":"1172_CR58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10641963.2014.954710","volume":"37","author":"L Luo","year":"2015","unstructured":"Luo L, Lin T, Zheng S, Xie Z, Chen M, Lian G, et al. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats. Clin Exp Hypertens. 2015;37(3):241\u20138.","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"1172_CR59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1159\/000430130","volume":"36","author":"P YanYun","year":"2015","unstructured":"YanYun P, Wang S, Yang J, Chen B, Sun Z, Ye L, et al. Interruption of CD40 pathway improves efficacy of transplanted endothelial progenitor cells in monocrotaline induced pulmonary arterial hypertension. Cell Physiol Biochem. 2015;36(2):683\u201396.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"1172_CR60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hlc.2016.08.002","volume":"26","author":"H Chen","year":"2017","unstructured":"Chen H, Yang H, Yue H, Strappe PM, Xia P, Pan L, et al. Mesenchymal stem cells expressing eNOS and a Cav1 mutant inhibit vascular smooth muscle cell proliferation in a rat model of pulmonary hypertension. Heart Lung Circ. 2017;26(5):509\u201318.","journal-title":"Heart Lung Circ"},{"issue":"2","key":"1172_CR61","volume":"11","author":"WC Huang","year":"2016","unstructured":"Huang WC, Ke MW, Cheng CC, Chiou SH, Wann SR, Shu CW, et al. Therapeutic benefits of induced pluripotent stem cells in monocrotaline-induced pulmonary arterial hypertension. PLoS One. 2016;11(2):e0142476.","journal-title":"PLoS One"},{"issue":"1","key":"1172_CR62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4070\/kcj.2016.46.1.79","volume":"46","author":"KC Kim","year":"2016","unstructured":"Kim KC, Lee JC, Lee H, Cho MS, Choi SJ, Hong YM. Changes in caspase-3, B cell leukemia\/lymphoma-2, interleukin-6, tumor necrosis factor-alpha and vascular endothelial growth factor gene expression after human umbilical cord blood derived mesenchymal stem cells transfusion in pulmonary hypertension rat models. Korean Circ J. 2016;46(1):79\u201392.","journal-title":"Korean Circ J"},{"issue":"1","key":"1172_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2016.03.046","volume":"473","author":"J Lim","year":"2016","unstructured":"Lim J, Kim Y, Heo J, Kim KH, Lee S, Lee SW, et al. Priming with ceramide-1 phosphate promotes the therapeutic effect of mesenchymal stem\/stromal cells on pulmonary artery hypertension. Biochem Biophys Res Commun. 2016;473(1):35\u201341.","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"1172_CR64","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1111\/bph.13562","volume":"173","author":"A Rathinasabapathy","year":"2016","unstructured":"Rathinasabapathy A, Bruce E, Espejo A, Horowitz A, Sudhan DR, Nair A, et al. Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis. Br J Pharmacol. 2016;173(19):2859\u201379.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1172_CR65","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/HYPERTENSIONAHA.116.08184","volume":"68","author":"R Varshney","year":"2016","unstructured":"Varshney R, Ali Q, Wu C, Sun Z. Monocrotaline-induced pulmonary hypertension involves downregulation of antiaging protein klotho and eNOS activity. Hypertension. 2016;68(5):1255\u201363.","journal-title":"Hypertension."},{"key":"1172_CR66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bcp.2017.04.024","volume":"138","author":"LA Ahmed","year":"2017","unstructured":"Ahmed LA, Rizk SM, El-Maraghy SA. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats. Biochem Pharmacol. 2017;138:193\u2013204.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1172_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13287-017-0480-y","volume":"8","author":"G Cheng","year":"2017","unstructured":"Cheng G, Wang X, Li Y, He L. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Stem Cell Res Ther. 2017;8(1):34.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1172_CR68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13287-017-0669-0","volume":"8","author":"L Mendonca de","year":"2017","unstructured":"de Mendonca L, Felix NS, Blanco NG, Da Silva JS, Ferreira TP, Abreu SC, et al. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. Stem Cell Res Ther. 2017;8(1):220.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"1172_CR69","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3349\/ymj.2017.58.3.570","volume":"58","author":"H Lee","year":"2017","unstructured":"Lee H, Kim KC, Choi SJ, Hong YM. Optimal dose and timing of umbilical stem cells treatment in pulmonary arterial hypertensive rats. Yonsei Med J. 2017;58(3):570\u201380.","journal-title":"Yonsei Med J"},{"issue":"8","key":"1172_CR70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183557","volume":"12","author":"RC Middleton","year":"2017","unstructured":"Middleton RC, Fournier M, Xu X, Marban E, Lewis MI. Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension. PLoS One. 2017;12(8):e0183557.","journal-title":"PLoS One"},{"issue":"1","key":"1172_CR71","first-page":"51","volume":"41","author":"L Luo","year":"2018","unstructured":"Luo L, Zheng W, Lian G, Chen H, Li L, Xu C, et al. Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK\/BMP\/Smad pathway. Int J Mol Med. 2018;41(1):51\u201360.","journal-title":"Int J Mol Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1172-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1172-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1172-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:13:23Z","timestamp":1583367203000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1172-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1172-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DS is an unpaid consultant and has an equity interest in Northern Therapeutics (Montr\u00e9al, QC, Canada). The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}